Cardiac SGLT2 Expression and Cell-Type-Specific Responses to Empagliflozin in iPSC-Derived Models of Diabetic Cardiomyopathy.

Su N, Phang RJ, Kong AM, MacIsaac RJ, Lim SY, Lees JG

Open source

DOI
10.3390/jcdd13070341
Published
2026 Jul 21
Container
Journal of cardiovascular development and disease
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jcdd13070341,
  title = {Cardiac SGLT2 Expression and Cell-Type-Specific Responses to Empagliflozin in iPSC-Derived Models of Diabetic Cardiomyopathy.},
  author = {Su N and Phang RJ and Kong AM and MacIsaac RJ and Lim SY and Lees JG},
  year = {2026},
  journal = {Journal of cardiovascular development and disease},
  doi = {10.3390/jcdd13070341},
  url = {https://doi.org/10.3390/jcdd13070341}
}

RIS

TY  - JOUR
TI  - Cardiac SGLT2 Expression and Cell-Type-Specific Responses to Empagliflozin in iPSC-Derived Models of Diabetic Cardiomyopathy.
AU  - Su N
AU  - Phang RJ
AU  - Kong AM
AU  - MacIsaac RJ
AU  - Lim SY
AU  - Lees JG
PY  - 2026
JO  - Journal of cardiovascular development and disease
DO  - 10.3390/jcdd13070341
UR  - https://doi.org/10.3390/jcdd13070341
ER  - 

APA

N, S., RJ, P., AM, K., RJ, M., SY, L., & JG, L. (2026). Cardiac SGLT2 Expression and Cell-Type-Specific Responses to Empagliflozin in iPSC-Derived Models of Diabetic Cardiomyopathy.. Journal of cardiovascular development and disease. https://doi.org/10.3390/jcdd13070341

Source records